Novo Nordisk CEO talks to MPs over Ozempic and Wegovy prices

Novo Nordisk’s CEO faced sharp questions about the cost of Ozempic and Wegovy on Capitol Hill on Tuesday, as lawmakers pressured the Danish pharmaceutical giant to cut the prices of its blockbuster diabetes and obesity drugs.